RxDoctor Payments Data

Amy Fletcher

Family · Spartanburg, SCNPI 1639208531

Payments from drug & device makers

$605in general payments, 2019–2025

Across 31 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$152
  • Sumitomo Pharma America, Inc.$105
  • AbbVie$65
  • Mayne Pharma Commercial LLC$59
  • Lilly USA, LLC$46
  • Exeltis, USA Inc.$31
  • plus $146 from 8 others

What the payments were for

  • Food & beverage$605100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$605 in reported general payments places this provider in the 55th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$3,106
Medicare patients
32
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol36$754
ValacyclovirValacyclovir Hcl16$424

Paid to pharmacies, not to this prescriber.

Other family in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →